BIOMAT Database Logo BIOMAT Database Logo

Effect of Fibroblast-Like Cells of Mesenchymal Origin of Cytotoxic Activity of Lymphocytes against NK-Sensitive Target Cells. 2017

A Yu Lupatov, and Ya S Kim, and O A Bystrykh, and I V Vakhrushev, and S V Pavlovich, and K N Yarygin, and G T Sukhikh
V. N. Orekhovich Research Institute of Biomedical Chemistry, Moscow, Russia. alupatov@inbox.ru.

We studied immunosuppressive properties of skin fibroblasts and mesenchymal stromal cells against NK cells. In vitro experiments showed that mesenchymal stromal cells isolated from human umbilical cord and human skin fibroblasts can considerably attenuate cytotoxic activity of NK cells against Jurkat cells sensitive to NK-mediated lysis. NK cells cultured in lymphocyte population exhibited higher cytotoxic activity than isolated NK cells. Mesenchymal stromal cells or fibroblasts added 1:1 to lymphocyte culture almost completely suppressed NK cell cytotoxicity. This suggests that fibroblast-like cells can suppress not only isolated NK cells, but also NK cells in natural cell microenvironment.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D059630 Mesenchymal Stem Cells Mesenchymal stem cells, also referred to as multipotent stromal cells or mesenchymal stromal cells are multipotent, non-hematopoietic adult stem cells that are present in multiple tissues, including BONE MARROW; ADIPOSE TISSUE; and WHARTON JELLY. Mesenchymal stem cells can differentiate into mesodermal lineages, such as adipocytic, osteocytic and chondrocytic. Adipose Tissue-Derived Mesenchymal Stem Cell,Adipose Tissue-Derived Mesenchymal Stromal Cell,Adipose-Derived Mesenchymal Stem Cell,Bone Marrow Mesenchymal Stem Cell,Mesenchymal Stromal Cell,Mesenchymal Stromal Cells,Multipotent Bone Marrow Stromal Cell,Multipotent Mesenchymal Stromal Cell,Adipose Tissue-Derived Mesenchymal Stem Cells,Adipose Tissue-Derived Mesenchymal Stromal Cells,Adipose-Derived Mesenchymal Stem Cells,Adipose-Derived Mesenchymal Stromal Cells,Bone Marrow Mesenchymal Stem Cells,Bone Marrow Stromal Cell,Bone Marrow Stromal Cells,Bone Marrow Stromal Cells, Multipotent,Bone Marrow Stromal Stem Cells,Mesenchymal Progenitor Cell,Mesenchymal Progenitor Cells,Mesenchymal Stem Cell,Mesenchymal Stem Cells, Adipose-Derived,Mesenchymal Stromal Cells, Multipotent,Multipotent Bone Marrow Stromal Cells,Multipotent Mesenchymal Stromal Cells,Stem Cells, Mesenchymal,Wharton Jelly Cells,Wharton's Jelly Cells,Adipose Derived Mesenchymal Stem Cell,Adipose Derived Mesenchymal Stem Cells,Adipose Derived Mesenchymal Stromal Cells,Adipose Tissue Derived Mesenchymal Stem Cell,Adipose Tissue Derived Mesenchymal Stem Cells,Adipose Tissue Derived Mesenchymal Stromal Cell,Adipose Tissue Derived Mesenchymal Stromal Cells,Mesenchymal Stem Cells, Adipose Derived,Progenitor Cell, Mesenchymal,Progenitor Cells, Mesenchymal,Stem Cell, Mesenchymal,Stromal Cell, Mesenchymal,Stromal Cells, Mesenchymal,Wharton's Jelly Cell,Whartons Jelly Cells
D061251 Primary Cell Culture The initial culturing of cells derived directly from fresh TISSUES. Cell Culture, Primary,Cell Cultures, Primary,Primary Cell Cultures

Related Publications

A Yu Lupatov, and Ya S Kim, and O A Bystrykh, and I V Vakhrushev, and S V Pavlovich, and K N Yarygin, and G T Sukhikh
Characterization of cloned cytotoxic lymphocytes with NK-like activity.
June 1983, Journal of immunology (Baltimore, Md. : 1950),
A Yu Lupatov, and Ya S Kim, and O A Bystrykh, and I V Vakhrushev, and S V Pavlovich, and K N Yarygin, and G T Sukhikh
Signal transduction in cytotoxic lymphocytes: decreased calcium influx in NK cell inactivated with sensitive target cells.
April 1993, Cellular immunology,
A Yu Lupatov, and Ya S Kim, and O A Bystrykh, and I V Vakhrushev, and S V Pavlovich, and K N Yarygin, and G T Sukhikh
Natural killer (NK) activity of porcine blood lymphocytes against allogeneic melanoma target cells.
August 1991, Veterinary immunology and immunopathology,
A Yu Lupatov, and Ya S Kim, and O A Bystrykh, and I V Vakhrushev, and S V Pavlovich, and K N Yarygin, and G T Sukhikh
A novel target cell antigen involved in the NK-like lytic activity of antigen-specific cytotoxic T lymphocytes.
September 1993, Immunology letters,
A Yu Lupatov, and Ya S Kim, and O A Bystrykh, and I V Vakhrushev, and S V Pavlovich, and K N Yarygin, and G T Sukhikh
Effect of human fibroblast interferon on the cytotoxic activity of natural killer cells and lymphocytes against autochthonous and allogeneic tumor cells.
October 1983, Gan,
A Yu Lupatov, and Ya S Kim, and O A Bystrykh, and I V Vakhrushev, and S V Pavlovich, and K N Yarygin, and G T Sukhikh
Activity of acid phosphatase in target binding cells expressing NK cytotoxic potential.
January 1987, Acta histochemica,
A Yu Lupatov, and Ya S Kim, and O A Bystrykh, and I V Vakhrushev, and S V Pavlovich, and K N Yarygin, and G T Sukhikh
The cytotoxic activity of mouse T lymphocytes against allogeneic cytotoxic T cells.
August 1975, Zeitschrift fur Immunitatsforschung, experimentelle und klinische Immunologie,
A Yu Lupatov, and Ya S Kim, and O A Bystrykh, and I V Vakhrushev, and S V Pavlovich, and K N Yarygin, and G T Sukhikh
[The effect of normal mouse serum and alloantibodies against target cell lymphocytes on the cytotoxic activity of immune lymphocytes].
March 1971, Biulleten' eksperimental'noi biologii i meditsiny,
A Yu Lupatov, and Ya S Kim, and O A Bystrykh, and I V Vakhrushev, and S V Pavlovich, and K N Yarygin, and G T Sukhikh
Peripheral blood lymphocytes resistant to Epstein-Barr virus immortalization manifest high natural killer (NK) type activity against NK-resistant target cells.
January 1990, Viral immunology,
A Yu Lupatov, and Ya S Kim, and O A Bystrykh, and I V Vakhrushev, and S V Pavlovich, and K N Yarygin, and G T Sukhikh
Lysis of NK target cells by soluble cytotoxic factor(s) and inhibition by a xenoantiserum directed against cytotoxic cells.
March 1981, Transplantation proceedings,
Copied contents to your clipboard!